Zhongjin Q. Yang
Tianjin, 300384, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Vilazodone inhibits NLRP3 inflammasome assembly by targeting the NACHT domain and alleviates inflammatory disease.
Journal: International immunopharmacology
Published: March 26, 2026
Correction to "Somatostatin and Mannooligosaccharide Modified Selenium Nanoparticles with Dual-Targeting for Ulcerative Colitis Treatment".
Journal: ACS nano
Published: August 05, 2025
Discovery of novel 8-hydroxyquinoline derivatives as NLRP3 inflammasome inhibitors with therapeutic potential for inflammatory bowel disease.
Journal: European journal of medicinal chemistry
Published: April 24, 2025
Discovery, synthesis, and biological mechanism evaluation of novel quinoline derivatives as potent NLRP3 inhibitors.
Journal: European journal of medicinal chemistry
Published: January 06, 2025
Artemisitene ameliorates carbon tetrachloride-induced liver fibrosis by inhibiting NLRP3 inflammasome activation and modulating immune responses.
Journal: International immunopharmacology
Published: September 07, 2024
Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase.
Journal: ACS central science
Published: May 18, 2024
Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 17, 2023
Investigation of a carbon monoxide poisoning accident with a hidden source
Journal: Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
Published: September 04, 2023
Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease.
Journal: RSC medicinal chemistry
Published: August 30, 2023
Last Updated: 09/26/2026